In this episode, anesthesiologist and venture capitalist Dr. Orrin Ailloni-Charas joins our host Dr. Bryan Hartley to discuss the mechanics of fundraising from both the entrepreneur and the investor side. 

First, they talk about the definition of venture capitalism (VC)  and its impact on GDP. Dr. Ailloni-Charas notes that the only way to get true and sustainable growth is through innovation of new products, opportunities, and industries. These efforts rely on VC for support. On a macro-level, new technologies require large investments in order to accelerate to the market. On a micro-level, each company also needs investment and guidance.

Dr. Aillioni-Charas walks through different stages of fundraising rounds: friends/family, seed, Series A, Series B, and so on. He says that each round should be centered around a milestone goal that advances the company closer to the final product and exit strategy. He also emphasizes the importance of storytelling and communicating product-market fit and uniqueness to potential investors.

From an investor standpoint, Dr. Aillioni-Charas highlights “green flags” and “red flags” that he has seen in startups. Positive factors are the presence of true clinical need, the ability to receive constructive feedback, and establishment functional oversight boards. Finally, we talk about the valuable clinical perspective that doctors can bring to a company and pathways that doctors can get involved in angel and VC investing.  

RESOURCES MENTIONED

Angel MD: https://angelmd.com/ 

Cura Capital: https://www.curacapital.co/